Clinical application of intact parathyroid hormone assays

Annals of Clinical Biochemistry

Volumn 34, Issue 6, 1997, Pages 588-598

  Ashby, J P ^a   Newman, D J ^b   Gow, S M ^c  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Hypercalcaemia; Hypocalcaemia; PTHrP; Renal failure

Indexed keywords

CALCIUM; PARATHYROID HORMONE;

DIFFERENTIAL DIAGNOSIS; HORMONE DETERMINATION; HORMONE METABOLISM; HORMONE SYNTHESIS; HYPERCALCEMIA; HYPOCALCEMIA; KIDNEY FAILURE; PARATHYROID HORMONE RELEASE; PRIORITY JOURNAL; REVIEW;

EID: 0030772826     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1177/000456329703400603     Document Type: Review

References (98)

1. Berson SA, Yalow RS, Aurbach GD, Potts JT. Immunoassay of bovine and human parathyroid hormone. Proc Natl Acad Sci USA 1963; 49: 613-7
2. Papapoulos SE, Manning RM, Hendy GN, Lewin IG, O'Riordan JLH. Studies of circulating parathyroid hormone in man using a homologous amino-terminal specific immunoradiometric assay. Clin Endocrinol 1980; 13: 57-67
3. Manning RM, Adami S, Papapoulos SE, Gleed JH, Hendy GN, Rosenblatt M, et al. A carboxy-terminal specific assay for human parathyroid hormone. Clin Endocrinol 1981; 15: 439-49
4. Mallette LE, Tuma SN, Berger RE, Kirkland JL. Radioimmunoassay for the middle region of human parathyroid hormone using an homologous antiserum with a carboxy terminal fragment of bovine parathyroid hormone as radioligand. J Clin Endocrinol Metab 1982; 54: 1017-24
5. Nussbaum SR, Zahradnik RJ, Lavigne JR, Brennan GL, Nozawa-Ung K, Kim LY, et al. Highly sensitive two-site immunoradiometric assay of parathyrin and its clinical utility in evaluating patients with hypercalcaemia. Clin Chem 1987; 33: 1364-7
6. Brown RC, Aston JP, Weeks I, Woodhead JS. Circulating intact parathyroid hormone measured by a two-site immunochemiluminometric assay. J Clin Endocrinol Metab 1987; 65: 407-14
7. Lunberg PA, Lindstedt G, Jansson S, Tisell LE. Assay of intact parathyrin in the immediate and long-term post operative follow-up of patients treated for hyperparathyroidism or thyroid tumour. Clin Chem 1989; 35: 340-1
8. Wood PJ. The measurement of parathyroid hormone. Ann Clin Biochem 1992; 29: 11-21
9. Fischer JA. Parathyroid hormone. In: Bronner F, Coburn J, eds. Disorders of Mineral Metabolism. London Academic Press, 1982: 271-358
10. Kronenberg HM, Bringhurst FR, Segre GV, Potts JT. Parathyroid hormone biosynthesis and metabolism. In: Bilezikian JP, Marcus R, Levine MA, eds. The Parathyroids, Basic and Clinical Concepts. New York: Raven Press, 1994: 125-37
11. Newman DJ, Ashby JP. Clinical and laboratory evaluation of a two-site immuno-radiometric assay for intact parathyroid hormone. Ann Clin Biochem 1988; 25: 654-60
12. Toffaletti J, Cooper DL, Lobaugh B. The response of parathyroid hormone to specific changes in ionized calcium ionized magnesium, or protein bound calcium in humans. Metabolism 1991; 40: 814-8
13. Rude RK. Parathyroid function in magnesium deficiency. In: Bilezikian JP, Marcus R, Levine MA, eds. The Parathyroids, Basic and Clinical Concepts. New York: Raven Press, 1994: 829-42
14. Kitamura N, Shigeno C, Shiomi K, Lee K, Ohta S, Sone T, et al. Episodic fluctuation in serum intact parathyroid hormone in men. J Clin Endocrinol Metab 1990; 70: 252-63
15. Logue FC, Fraser WD, O'Reilly D StJ, Beastall GH. The arcadian rhythm of intact parathyroid hormone (1-84) and nephrogenous cyclic adenosine monophosphate in normal men. J Endocrinol 1989; 121: R1-R3
16. Logue FC, Fraser WD, Gallacher SJ, Cameron DA, O'Reilly D StJ, Beastall GH, et al. The loss of circadian rhythm for intact parathyroid hormone and nephrogenous cyclic AMP in patients with primary hyperparathyroidism. Clin Endocrinol 1990; 32: 475-83
17. Logue FC, Beastall GH, Fraser WD, O'Reilly D StJ. Intact parathyroid hormone assays. Br Med J 1990; 300: 210-1
18. Calvo MS, Eastell R, Offord KP, Bergstralh EJ, Burritt MF. Circadian variation in ionised calcium and intact parathyroid hormone: evidence for sex differences in calcium homeostasis. J Clin Endocrinol Metab 1991; 72: 69-76
19. Campbell GA, Kemm JR, Hosking DJ, Boyd RV. How common is osteomalacia in the elderly? Lancet 1984; ii: 386-8
20. Orrell DH. Albumin as an aid to the interpretation of serum calcium. Clin Chim Acta 1971; 35: 483-9
21. Payne RB, Little AJ, Williams RB, Milner JR. Interpretation of serum calcium in patients with abnormal serum proteins. Br Med J 1973; 4: 643-6
22. Imrie CW, Allam BF, Ferguson JC. Hypocalcaemia in acute pancreatitis: the effect of hypoalbuminaemia. Curr Med Res Opinion 1976; 4: 101-16
23. Barth JH, Fiddy JB, Payne RB. Adjustment of serum total calcium for albumin concentration: effects of non-linearity and of regression differences between laboratories. Ann Clin Biochem 1996; 33: 55-8
24. Ashby JP, Wright DJ, Rinsler MG. The adjusted calcium concept - a reappraisal. Ann Clin Biochem 1986; 23: 533-7
25. Heath H, Purnell DC. Asymptomatic hypercalcemia and primary hyperparathyroidism. In: Heath DA, Marx SJ, eds. Calcium Disorders. London: Butterworth Scientific 1982: 189-216
26. Fisken RA, Health DA, Somers S, Bold AM. Hypercalcaemia in hospital patients. Clinical and diagnostic aspects. Lancet 1981; 1: 202-7
27. Harrop JS, Bailey JE, Woodhead JS. Incidence of hypercalcaemia and hyperparathyroidism in relation to the biochemical profile. J Clin Pathol 1982; 35: 395-400
28. Gardin JP, Paillard M. Normocalcaemic primary hyperparathyroidism: resistance to PTH effect on tubular reabsorption of calcium. Min Elect Metab 1984; 10: 301-8
29. Broadus AE, Horst RL, Littledike ET, Mahaffey JE, Rasmussen H. Primary hyperparathyroidism with intermittent hypercalcaemia: serial observations and differential diagnosis by means of an oral calcium tolerance test. Clin Endocrinol 1980; 12: 225-35
30. Klugman VA, Farns MJ, Pak CYC. Nephrolithiasis in primary hyperparathyroidism. In: Bilezikian JP, Marcus R, Levine MA, eds. The Parathyroids, Basic and Clinical Concepts. New York: Raven Press, 1994: 505-17
31. Insogna KL, Broadus AE. Nephrolithiasis. In: Felig P, Baxter JD, Broadus AE, Froham LA, eds. Endocrinology and Metabolism. New York: McGraw-Hill 1987: 1500-77
32. Heath H. Familial benign (hypocalciuric) hypercalcemia: a troublesome mimic of primary hyperathyroidism. Endocrinol Metab Clin North Am 1989; 18: 723-40
33. Marx SJ, Attie MF, Levine MA, Spiegel AM, Downs RW, Lasker RD. The hypocalciuric or benign variant of familial hypercalcaemia: clinical and biochemical features in fifteen kindreds. Medicine 1981; 60: 397-412
34. Stuckley BGA, Kent GN, Gutteridge DH, Pullan PT, Price RI, Bhagat C. Fasting calcium excretion and parathyroid hormone together distinguish familial hypocalciuric hypercalcaemia from primary hyperparathyroidism. Clin Endocrinol 1987; 27: 525-33
35. Gunn IR, Wallace JR. Urine calcium and serum ionised calcium, total calcium and parathyroid hormone concentrations in the diagnosis of primary hyperparathyroidism and familial benign hypercalcaemia. Ann Clin Biochem 1992; 29: 52-8
36. Heath DA. Familial hypocalciuric hypercalcaemia. In: Bilezikian JP, Levine MA, Marcus R, eds. The Parathyroids, Basic and Clinical Concepts New York: Raven Press, 1994: 699-710
37. Firek AF, Kao PC, Heath H. Plasma intact parathyroid hormone (PTH) and PTH-related peptide in familial benign hypercalcemia: greater responsiveness to endogenous PTH than in primary hyperparathyroidism. J Clin Endocrinol Metab 1991: 72: 541-6
38. McMurtry CT, Schranck FW, Walkenhorst DA, Murphy WA, Kocher DB, Teitelbaum SL, et al. Significant developmental elevation in serum parathyroid hormone levels in a large kindred with familial benign (hypocalciuric) hypercalcaemia. Am J Med 1992; 93: 247-58
39. Langman CB, Budayr AA, Sailer DE, Strewler GJ. Non malignant expression of PTHRP is responsible for idiopathic infantile hypercalcemia. J Bone Mineral Res 1992; (suppl 1); S93
40. Flentje D, Schmidt-Gayk H, Fischer S, Stern J, Blind E, Buhr H, et al. Intact parathyroid hormone in primary hyperparathyroidism. Br J Surg 1990; 77: 168-72
41. Newman DJ, Thakkar H, Ashby JP. Clinical utility of region-specific assays in the investigation of hypercalcaemia. Ann Clin Biochem 1987; 24 (suppl 1): 150-1
42. Blind E, Schmidt-Gayk H, Scharla S, Flentje D, Fischer S, Gohring U, et al. Two-site assay of intact parathyroid hormone in the investigation of primary hyperparathyroidism and other disorders of calcium metabolism compared with a mid-region assay. J Clin Endocrinol Metab 1988; 67: 353-60
43. Aston P, Wheeler MH, Brown RC, Curley IR, Woodhead SJ. Laboratory comparison of diagnostic specificity of intact hormone and region-specific immunoassays of parathyroid hormone. World J Surg 1990; 14: 419-24
44. Ljunghall S, Larsson K, Lindh E, Lindquvst U, Rastas J, Akerstrom G, et al. Disturbance of basal and stimulated intact parathyroid hormone in primary hyperparathyroidism. Surgery 1991; 110: 47-53
45. Blind E, Raue F, Gotzmann J, Schmidt-Gayk H, Kohl B, Zeigler R. Circulating levels of mid-regional parathyroid hormone-related protein in hypercalcaemia of malignancy. Clin Endocrinol 1992; 37: 290-7
46. Mundy GR, Ibbotson KJ, D'Souza SM. Tumor products and the hypercalcaemia of malignancy. J Clin Invest 1985: 76: 391-4
47. Yoshimoto K, Yamasaki R, Sakai H, Tezuka U, Takahashi M, I'Zuka M, et al. Ectopic production of parathyroid hormone by small cell lung cancer in a patient with hypercalcemia. J Clin Endocrinol Metab 1989; 68: 976-81
48. Nussbaum SR, Gaz RD, Arnold A. Hypercalcaemia and ectopic secretion of parathyroid hormone by an ovarian carcinoma with rearrangement of the gene for parathyroid hormone. N Engl J Med 1990; 323: 1324-8
49. Strewler GJ, Budayr AA, Clark OH, Nissenson RA. Production of parathyroid hormone by a malignant non parathyroid tumour in a hypercalcaemic patient. J Clin Endocr Metab 1993; 76: 1373-5
50. Suva LJ, Winslow GA, Wettenhall REH, Hammonds RG, Moseley JM, Diefenbach-Jagger H, et al. A parathyroid hormone-related protein implicated in malignant hypercalcaemia: cloning and expression. Science 1987; 237: 893-6
51. Boscato LM, Stuart MC. Incidence and specificity of interference in two-site immunoassays. Clin Chem 1986; 32: 1491-5
52. Clark PM, Raggatt PR, Price CP. Antibodies interfering in immunometric assays. Clin Chem 1985;31:1762
53. Cusick CF, Mistry K, Addison GM. Interference in a two-site immunoradiometric assay for thyrotropin in a child. Clin Chem 1985; 31: 348-9
54. Hunter WM, Budd PS. Circulating antibodies to ovine and bovine immunoglobulins in healthy subjects: A hazard for immunoassays. Lancet 1980; ii: 1136
55. Mallette LE, Nammour H. False positive elevations of midregion parathyroid hormone: inhibition of radioligand binding by a heterophilic antibody in patient serum [Abstract 134]. In: Cohn DU, Martin TJ, Meunier PJ. Calcium Regulation and Bone Metabolism: Basic and Clinical Aspects: Proceedings of 9th International Conference on Metabolism. Amsterdam, New York: Excerpta; Elsevier Science, 1987.
56. Wilkinson M, McElduff A, Wilson J, Haber P, Freeman A, Robertson M, et al. Spontaneously occurring antibodies to parathyroid hormone. J Clin Endocrinol Metab 1990; 70: 1744-9
57. Kasono K, Sato K, Suzuki T, Ohmura E, Demura R, Shizume K, et al. Falsely elevated serum parathyroid hormone levels due to immunoglobulin G in a patient with idiopathic hypoparathyroidism. J Clin Endocrinol Metab 1991; 72: 217-22
58. Ashby JP, Loveridge N, Brown RC, Zanelli JM, Rinsler MG, Watts RWE. Anomalies in the assay of parathyroid hormone in normocalcaemic patients with renal stone disease. Clin Endocrinol 1988; 29: 131-40
59. Lips P, Netelenbos JC, van Doorn L, Hackeng WHL, Lips CJM. Stimulation and suppression of intact parathyroid hormone (PTH 1-84) in normal and hyperparathyroid patients. Clin Endocrinol 1991; 35: 35-40
60. Salazar J, Dembrow V, Egozi I. A review of 265 cases of parathyroid explorations. Am Surgeon 1986; 52: 174-6
61. Statava RM, Beahrs OH, Scholz DA. Success rate of cervical exploration for hyperparathyroidism. Arch Surg 1975; 110: 625-8
62. Doppman JL. Preoperative localisation of parathyroid tissue in primary hyperparathyroidism. In: Bilezikian JP, Marcus R, Levine MA, eds. The Parathyroids, Basic and Clinical Concepts. New York: Raven Press, 1994: 553-65
63. Fine EJ. Parathyroid imaging: its current status and future role. Sem Nucl Med 1987; 17: 350-9
64. McKillop JH, Boyle IT, Gunn IG, Hutchison JSF. Preoperative localisation of parathyroid adenomas. Scot Med J 1986; 31: 10-14
65. Beastall GH, McKellar N, Boyle IT, Joffe SN, Hutchison JSF, Boyce BF, et al. Preoperative localisation of parathyoid tumours using neck vein catheterisation and radioimmunoassay for parathyroid hormone: the Glaseow experience. Scot Med J 1983; 18: 146-52
66. Dunlop DAB, Papapoulos SE, Lodge RW, Fulton AJ, Kendall BE, O'Riordan JLH. Parathyroid venous sampling: anatomic considerations and results in 95 patients with primary hyperparathyroidsim. Br J Radiol 1980; 53: 183-91
67. Brennan MF, Doppman JL, Kurdy AG, Marx SJ, Spiegel MM, Auerbach GD. Assessment of techniques for preoperative parathyroid gland localisation in patients undergoing reoperation for hyperparathyroidism. Surgery 1982; 91: 6-11
68. Young AE, Gaunt JL, Croft DN, Collins RE, Wells CP, Coakley AJ. Localisation of parathyroid adenomas by Thallium-201 and Technetium-99m subtraction scanning. Br Med J 1983; 286: 1384-6
69. Ferlin G, Borsato N, Camerani M, Conte N, Zotti D. New perspectives in localising enlarged parathyroid glands by Technetium-Thallium subtraction scan. J Nucl Med 1983; 24: 438-41
70. Stewart AF, Broadus AE. Mineral metabolism. In: Felig P, Baxter JD, Broadus AE, Frohman LA, eds. Endocrinology and Metabolism. New York: McGraw-Hill, 1987: 1317-453
71. Livingstone JI, Tellez M, Burke M, Ashby PJ, Rinsler MG. A five year audit of the role of parathyroid hormone assays and thallium-technetium isotype subtraction scanning in the preoperative investigation of primary hyperparathyroidism. Postgrad Med J 1991; 67: 1055-8
72. Brasier AR, Wang CA, Nussbaum SR. Recovery of parathyroid hormone secretion after parathyroid adenomectomy. J Clin Endocrinol Metab 1988; 66: 495-500
73. Nussbaum SR, Thomson AR, Hutcheson KA, Gaz RD, Wang C. Intraoperative measurement of parathyroid hormone in the surgical measurement of hyperparathyroidism. Surgery 1988; 104: 1121-7
74. Ryan MF, Jones SR, Barnes AD. Intraoperative monitoring of parathyroid hormone levels using a rapid immunoradiometric assay method. Ann Clin Biochem 1990; 27: 65-8
75. Ryan MF, Jones SR, Barnes AD. Clinical evaluation of a rapid parathyroid hormone assay. Ann Clin Biochem 1992; 29: 48-51
76. Wilkinson H. Hyperparathyroidism. Ann Clin Biochem 1990; 27: 603
77. Desai TK, Carlson RW, Geheb MA. Prevalence and clinical implications of hypocalcaemia in acutely ill patients in the medical intensive care setting. Am J Med 1988; 84: 209-14
78. Chernow B, Zaloga G, McFadden E, Clapper M, Kotler M, Barton M, et al. Hypocalcemia in critically ill patients. Crit Care Med 1982; 10: 848-51
79. Derasmo AU, Celi FS, Ace M, Ministola S, Aliberti G, Mazzuroli GF. Hypocalcemia and hypomagnesemia in cancer patients. Biomed Pharmacol 1991; 45: 315-7
80. Ashby JP, Newman DJ, Rinsler MG. Is intact PTH a sensitive biochemical indicator of deranged calcium homeostasis in Vitamin D deficiency? Ann Clin Biochem 1989; 26: 324-7
81. Lips P. Vitamin D deficiency and osteoporosis; the role of vitamin D deficiency and treatment with vitamin D and analogues in the prevention of osteoporosis-related fractures. Eur J Clin Invest 1996; 26: 436-42
82. Rude RK, Oldham SB, Singer FR. Functional hypoparathyroidism and parathyroid hormone end-organ resistance in human magnesium deficiency. Clin Endocrinol 1976; 5: 209-24
83. Mayne PD, Kovar IZ. Calcium and phosphorus metabolism in the premature infant. Ann Clin Biochem 1991; 28: 131-42
84. Hillman LS, Haddad JG. Hypocalcaemia and other abnormalities of mineral homeostatsis during the neonatal period. In: Heath DA, Marx SJ, eds. Calcium Disorders. London: Butterworth Scientific, 1982: 248-76
85. Ott SM, Maloney NA, Coburn JW, Alfrey AC, Sherrard DJ. The prevalence of bone aluminium deposition in renal osteodystrophy and its relation to the response to calcitriol. N Engl J Med 1982; 307: 709-13
86. Felsenfield AJ, Llach F. Parathyroid gland function in chronic renal failure. Kidney Int 1993; 43: 771-89
87. Hercz G, Pei C, Greenwood A, Manuel A, Saiphoo C, Goodman WG, et al. Aplastic osteodystrophy without aluminium: the role of "suppressed" parathyroid function. Kidney Int 1993; 44: 860-6
88. Andress DL, Endres DB, Maloney NA, Kopp JB, Coburn JW, Sherrard DJ. Comparison of parathyroid assays with bone histomorphometry in renal osteodystrophy. J Clin Endocrinol Metab 1986; 63: 1163-9
89. Morita A, Tabata T, Koyama H, Emoto M, Inoue T, Miki T, et al. A two-site immunochemiluminometric assay for intact parathyroid hormone and its clinical utility in haemodialysis patients. Clin Nephrol 1992; 38: 154-7
90. Saha H, Pietila K, Mustonen J, Pasternack A, Morsky P. Acute effect of dialysate calcium concentration and intravenous vitamin D3 on the secretion of parathyroid hormone in haemodialysis patients. Clin Nephrol 1992; 38: 145-8
91. Quarles LD, Lobough B, Murphy G. Intact parathyroid hormone over-estimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia. J Clin Endocrinol Metab 1992; 75: 145-50
92. Hutchison AJ, Whitehouse RW, Boulton HF, Adams JE, Mawer EB, Freemont TJ, et al. Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease. Kidney Int 1993; 44: 1071-7
93. Salusky IB, Ramirez JA, Oppenheim W, Gales B, Segre GV, Goodman WG. Biochemical markers of renal oteodystrophy in paediatric patients undergoing CAPD/CCPD. Kidney Int 1994; 45: 253-8
94. Gladziwa U, Ittel TH, Dakshinamurty KV, Schacht B, Riehl J, Sieberth HG. Secondary hyperparathyroidism and sonographic evaluation of parathyroid gland hyperplasia in dialysis patients. Clin Nephrol 1992; 38: 162-6
95. Tibi L, Chhabra SC, Sweeting VM, Winney RJ, Smith AF. Mutiple forms of alkaline phosphatase in plasma of haemodialysis patients. Clin Chem 1991; 37: 815-20
96. Andress DL, Norris KC, Coburn JW, Slatopolsky EA, Sherrard DJ. Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. N Engl J Med 1989; 321: 274-9
97. Hutchison AJ, Freemont AJ, Boulton HF, Gokal R. Low-calcium dialysis fluid and oral calcium carbonate in CAPD. A method of controlling hyperphosphataemia whilst minimizing aluminium exposure and hypercalcaemia. Nephrol Dial Transplant 1992; 7: 1219-25
98. Coen G, Mazzaferro S, Ballanti P, Bonucci E, Cinotti GA, Fondi G, et al. Two-site immunometric intact parathyroid hormone assay versus C-terminal parathyroid hormone in predicting osteodystrophic bone lesions in predialysis chronic renal failure. J Lab Clin Med 1993; 122: 103-9